Haddad, R., Concha‐Benavente, F., Blumenschein, G., Fayette, J., Guigay, J., Colevas, A. D., Licitra, L., Kasper, S., Vokes, E. E., Worden, F., Saba, N. F., Tahara, M., Jayaprakash, V., Lynch, M., Li, L., Gillison, M. L., Harrington, K. J., & Ferris, R. L. (2019). nivolumab treatment beyond RECIST‐defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial. Cancer, 125(18), 3208–3218. http://access.bl.uk/ark:/81055/vdc_100090082124.0x000062